Drug Profile
LY 3143753
Alternative Names: LY3143753Latest Information Update: 28 Feb 2018
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class
- Mechanism of Action Glucagon receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hypoglycaemia
Most Recent Events
- 28 Feb 2018 No recent reports of development identified for phase-I development in Hypoglycaemia(In volunteers) in United Kingdom (SC, Injection)
- 01 Jan 2015 Phase-I clinical trials in healthy volunteers in United Kingdom (SC)